1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Infectious Disease Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Antibacterials 1.2.3 Antiviral drugs 1.2.4 Antiparasitic drugs 1.2.5 Antifungal 1.2.6 Others 1.3 Market by Application 1.3.1 Global Infectious Disease Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 HIV 1.3.3 Malaria 1.3.4 Hepatitis 1.3.5 Influenza 1.3.6 HPV 1.3.7 Tuberculosis 1.3.8 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Infectious Disease Drugs Market Perspective (2016-2027) 2.2 Infectious Disease Drugs Growth Trends by Regions 2.2.1 Infectious Disease Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Infectious Disease Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Infectious Disease Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Infectious Disease Drugs Industry Dynamic 2.3.1 Infectious Disease Drugs Market Trends 2.3.2 Infectious Disease Drugs Market Drivers 2.3.3 Infectious Disease Drugs Market Challenges 2.3.4 Infectious Disease Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Infectious Disease Drugs Players by Revenue 3.1.1 Global Top Infectious Disease Drugs Players by Revenue (2016-2021) 3.1.2 Global Infectious Disease Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Infectious Disease Drugs Revenue 3.4 Global Infectious Disease Drugs Market Concentration Ratio 3.4.1 Global Infectious Disease Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Drugs Revenue in 2020 3.5 Infectious Disease Drugs Key Players Head office and Area Served 3.6 Key Players Infectious Disease Drugs Product Solution and Service 3.7 Date of Enter into Infectious Disease Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Infectious Disease Drugs Breakdown Data by Type 4.1 Global Infectious Disease Drugs Historic Market Size by Type (2016-2021) 4.2 Global Infectious Disease Drugs Forecasted Market Size by Type (2022-2027) 5 Infectious Disease Drugs Breakdown Data by Application 5.1 Global Infectious Disease Drugs Historic Market Size by Application (2016-2021) 5.2 Global Infectious Disease Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Infectious Disease Drugs Market Size (2016-2027) 6.2 North America Infectious Disease Drugs Market Size by Type 6.2.1 North America Infectious Disease Drugs Market Size by Type (2016-2021) 6.2.2 North America Infectious Disease Drugs Market Size by Type (2022-2027) 6.2.3 North America Infectious Disease Drugs Market Size by Type (2016-2027) 6.3 North America Infectious Disease Drugs Market Size by Application 6.3.1 North America Infectious Disease Drugs Market Size by Application (2016-2021) 6.3.2 North America Infectious Disease Drugs Market Size by Application (2022-2027) 6.3.3 North America Infectious Disease Drugs Market Size by Application (2016-2027) 6.4 North America Infectious Disease Drugs Market Size by Country 6.4.1 North America Infectious Disease Drugs Market Size by Country (2016-2021) 6.4.2 North America Infectious Disease Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Infectious Disease Drugs Market Size (2016-2027) 7.2 Europe Infectious Disease Drugs Market Size by Type 7.2.1 Europe Infectious Disease Drugs Market Size by Type (2016-2021) 7.2.2 Europe Infectious Disease Drugs Market Size by Type (2022-2027) 7.2.3 Europe Infectious Disease Drugs Market Size by Type (2016-2027) 7.3 Europe Infectious Disease Drugs Market Size by Application 7.3.1 Europe Infectious Disease Drugs Market Size by Application (2016-2021) 7.3.2 Europe Infectious Disease Drugs Market Size by Application (2022-2027) 7.3.3 Europe Infectious Disease Drugs Market Size by Application (2016-2027) 7.4 Europe Infectious Disease Drugs Market Size by Country 7.4.1 Europe Infectious Disease Drugs Market Size by Country (2016-2021) 7.4.2 Europe Infectious Disease Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Infectious Disease Drugs Market Size (2016-2027) 8.2 Asia-Pacific Infectious Disease Drugs Market Size by Type 8.2.1 Asia-Pacific Infectious Disease Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Infectious Disease Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Infectious Disease Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Infectious Disease Drugs Market Size by Application 8.3.1 Asia-Pacific Infectious Disease Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Infectious Disease Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Infectious Disease Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Infectious Disease Drugs Market Size by Region 8.4.1 Asia-Pacific Infectious Disease Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Infectious Disease Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Infectious Disease Drugs Market Size (2016-2027) 9.2 Latin America Infectious Disease Drugs Market Size by Type 9.2.1 Latin America Infectious Disease Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Infectious Disease Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Infectious Disease Drugs Market Size by Type (2016-2027) 9.3 Latin America Infectious Disease Drugs Market Size by Application 9.3.1 Latin America Infectious Disease Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Infectious Disease Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Infectious Disease Drugs Market Size by Application (2016-2027) 9.4 Latin America Infectious Disease Drugs Market Size by Country 9.4.1 Latin America Infectious Disease Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Infectious Disease Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Infectious Disease Drugs Market Size (2016-2027) 10.2 Middle East & Africa Infectious Disease Drugs Market Size by Type 10.2.1 Middle East & Africa Infectious Disease Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Infectious Disease Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Infectious Disease Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Infectious Disease Drugs Market Size by Application 10.3.1 Middle East & Africa Infectious Disease Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Infectious Disease Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Infectious Disease Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Infectious Disease Drugs Market Size by Country 10.4.1 Middle East & Africa Infectious Disease Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Infectious Disease Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Company Details 11.1.2 GlaxoSmithKline Business Overview 11.1.3 GlaxoSmithKline Infectious Disease Drugs Introduction 11.1.4 GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2016-2021) 11.1.5 GlaxoSmithKline Recent Development 11.2 Gilead Sciences 11.2.1 Gilead Sciences Company Details 11.2.2 Gilead Sciences Business Overview 11.2.3 Gilead Sciences Infectious Disease Drugs Introduction 11.2.4 Gilead Sciences Revenue in Infectious Disease Drugs Business (2016-2021) 11.2.5 Gilead Sciences Recent Development 11.3 Merck & Co. 11.3.1 Merck & Co. Company Details 11.3.2 Merck & Co. Business Overview 11.3.3 Merck & Co. Infectious Disease Drugs Introduction 11.3.4 Merck & Co. Revenue in Infectious Disease Drugs Business (2016-2021) 11.3.5 Merck & Co. Recent Development 11.4 Pfizer 11.4.1 Pfizer Company Details 11.4.2 Pfizer Business Overview 11.4.3 Pfizer Infectious Disease Drugs Introduction 11.4.4 Pfizer Revenue in Infectious Disease Drugs Business (2016-2021) 11.4.5 Pfizer Recent Development 11.5 Sanofi 11.5.1 Sanofi Company Details 11.5.2 Sanofi Business Overview 11.5.3 Sanofi Infectious Disease Drugs Introduction 11.5.4 Sanofi Revenue in Infectious Disease Drugs Business (2016-2021) 11.5.5 Sanofi Recent Development 11.6 AbbVie 11.6.1 AbbVie Company Details 11.6.2 AbbVie Business Overview 11.6.3 AbbVie Infectious Disease Drugs Introduction 11.6.4 AbbVie Revenue in Infectious Disease Drugs Business (2016-2021) 11.6.5 AbbVie Recent Development 11.7 Shire 11.7.1 Shire Company Details 11.7.2 Shire Business Overview 11.7.3 Shire Infectious Disease Drugs Introduction 11.7.4 Shire Revenue in Infectious Disease Drugs Business (2016-2021) 11.7.5 Shire Recent Development 11.8 Grifols 11.8.1 Grifols Company Details 11.8.2 Grifols Business Overview 11.8.3 Grifols Infectious Disease Drugs Introduction 11.8.4 Grifols Revenue in Infectious Disease Drugs Business (2016-2021) 11.8.5 Grifols Recent Development 11.9 Johnson & Johnson 11.9.1 Johnson & Johnson Company Details 11.9.2 Johnson & Johnson Business Overview 11.9.3 Johnson & Johnson Infectious Disease Drugs Introduction 11.9.4 Johnson & Johnson Revenue in Infectious Disease Drugs Business (2016-2021) 11.9.5 Johnson & Johnson Recent Development 11.10 Protein Sciences 11.10.1 Protein Sciences Company Details 11.10.2 Protein Sciences Business Overview 11.10.3 Protein Sciences Infectious Disease Drugs Introduction 11.10.4 Protein Sciences Revenue in Infectious Disease Drugs Business (2016-2021) 11.10.5 Protein Sciences Recent Development 11.11 AstraZeneca 11.11.1 AstraZeneca Company Details 11.11.2 AstraZeneca Business Overview 11.11.3 AstraZeneca Infectious Disease Drugs Introduction 11.11.4 AstraZeneca Revenue in Infectious Disease Drugs Business (2016-2021) 11.11.5 AstraZeneca Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Infectious Disease Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Antibacterials Table 3. Key Players of Antiviral drugs Table 4. Key Players of Antiparasitic drugs Table 5. Key Players of Antifungal Table 6. Key Players of Others Table 7. Global Infectious Disease Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Infectious Disease Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Infectious Disease Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Infectious Disease Drugs Market Share by Regions (2016-2021) Table 11. Global Infectious Disease Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Infectious Disease Drugs Market Share by Regions (2022-2027) Table 13. Infectious Disease Drugs Market Trends Table 14. Infectious Disease Drugs Market Drivers Table 15. Infectious Disease Drugs Market Challenges Table 16. Infectious Disease Drugs Market Restraints Table 17. Global Infectious Disease Drugs Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Infectious Disease Drugs Market Share by Players (2016-2021) Table 19. Global Top Infectious Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Drugs as of 2020) Table 20. Ranking of Global Top Infectious Disease Drugs Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Infectious Disease Drugs Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Infectious Disease Drugs Product Solution and Service Table 24. Date of Enter into Infectious Disease Drugs Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Infectious Disease Drugs Market Size by Type (2016-2021) (US$ Million) Table 27. Global Infectious Disease Drugs Revenue Market Share by Type (2016-2021) Table 28. Global Infectious Disease Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Infectious Disease Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Infectious Disease Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Infectious Disease Drugs Revenue Market Share by Application (2016-2021) Table 32. Global Infectious Disease Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Infectious Disease Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Infectious Disease Drugs Market Size by Type (2016-2021) (US$ Million) Table 35. North America Infectious Disease Drugs Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Infectious Disease Drugs Market Size by Application (2016-2021) (US$ Million) Table 37. North America Infectious Disease Drugs Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Infectious Disease Drugs Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Infectious Disease Drugs Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Infectious Disease Drugs Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Infectious Disease Drugs Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Infectious Disease Drugs Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Infectious Disease Drugs Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Infectious Disease Drugs Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Infectious Disease Drugs Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Infectious Disease Drugs Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Infectious Disease Drugs Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Infectious Disease Drugs Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Infectious Disease Drugs Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Infectious Disease Drugs Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Infectious Disease Drugs Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Infectious Disease Drugs Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Infectious Disease Drugs Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Infectious Disease Drugs Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Infectious Disease Drugs Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Infectious Disease Drugs Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Infectious Disease Drugs Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Infectious Disease Drugs Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Infectious Disease Drugs Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Infectious Disease Drugs Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Infectious Disease Drugs Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Infectious Disease Drugs Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Infectious Disease Drugs Market Size by Country (2022-2027) & (US$ Million) Table 64. GlaxoSmithKline Company Details Table 65. GlaxoSmithKline Business Overview Table 66. GlaxoSmithKline Infectious Disease Drugs Product Table 67. GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million) Table 68. GlaxoSmithKline Recent Development Table 69. Gilead Sciences Company Details Table 70. Gilead Sciences Business Overview Table 71. Gilead Sciences Infectious Disease Drugs Product Table 72. Gilead Sciences Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million) Table 73. Gilead Sciences Recent Development Table 74. Merck & Co. Company Details Table 75. Merck & Co. Business Overview Table 76. Merck & Co. Infectious Disease Drugs Product Table 77. Merck & Co. Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million) Table 78. Merck & Co. Recent Development Table 79. Pfizer Company Details Table 80. Pfizer Business Overview Table 81. Pfizer Infectious Disease Drugs Product Table 82. Pfizer Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million) Table 83. Pfizer Recent Development Table 84. Sanofi Company Details Table 85. Sanofi Business Overview Table 86. Sanofi Infectious Disease Drugs Product Table 87. Sanofi Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million) Table 88. Sanofi Recent Development Table 89. AbbVie Company Details Table 90. AbbVie Business Overview Table 91. AbbVie Infectious Disease Drugs Product Table 92. AbbVie Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million) Table 93. AbbVie Recent Development Table 94. Shire Company Details Table 95. Shire Business Overview Table 96. Shire Infectious Disease Drugs Product Table 97. Shire Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million) Table 98. Shire Recent Development Table 99. Grifols Company Details Table 100. Grifols Business Overview Table 101. Grifols Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million) Table 102. Grifols Recent Development Table 103. Johnson & Johnson Company Details Table 104. Johnson & Johnson Business Overview Table 105. Johnson & Johnson Infectious Disease Drugs Product Table 106. Johnson & Johnson Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million) Table 107. Johnson & Johnson Recent Development Table 108. Protein Sciences Company Details Table 109. Protein Sciences Business Overview Table 110. Protein Sciences Infectious Disease Drugs Product Table 111. Protein Sciences Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million) Table 112. Protein Sciences Recent Development Table 113. AstraZeneca Company Details Table 114. AstraZeneca Business Overview Table 115. AstraZeneca Infectious Disease Drugs Product Table 116. AstraZeneca Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million) Table 117. AstraZeneca Recent Development Table 118. Research Programs/Design for This Report Table 119. Key Data Information from Secondary Sources Table 120. Key Data Information from Primary Sources List of Figures Figure 1. Global Infectious Disease Drugs Market Share by Type: 2020 VS 2027 Figure 2. Antibacterials Features Figure 3. Antiviral drugs Features Figure 4. Antiparasitic drugs Features Figure 5. Antifungal Features Figure 6. Others Features Figure 7. Global Infectious Disease Drugs Market Share by Application: 2020 VS 2027 Figure 8. HIV Case Studies Figure 9. Malaria Case Studies Figure 10. Hepatitis Case Studies Figure 11. Influenza Case Studies Figure 12. HPV Case Studies Figure 13. Tuberculosis Case Studies Figure 14. Others Case Studies Figure 15. Infectious Disease Drugs Report Years Considered Figure 16. Global Infectious Disease Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 17. Global Infectious Disease Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 18. Global Infectious Disease Drugs Market Share by Regions: 2020 VS 2027 Figure 19. Global Infectious Disease Drugs Market Share by Regions (2022-2027) Figure 20. Global Infectious Disease Drugs Market Share by Players in 2020 Figure 21. Global Top Infectious Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Drugs as of 2020 Figure 22. The Top 10 and 5 Players Market Share by Infectious Disease Drugs Revenue in 2020 Figure 23. Global Infectious Disease Drugs Revenue Market Share by Type (2016-2021) Figure 24. Global Infectious Disease Drugs Revenue Market Share by Type (2022-2027) Figure 25. North America Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. North America Infectious Disease Drugs Market Share by Type (2016-2027) Figure 27. North America Infectious Disease Drugs Market Share by Application (2016-2027) Figure 28. North America Infectious Disease Drugs Market Share by Country (2016-2027) Figure 29. United States Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Canada Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Europe Infectious Disease Drugs Market Share by Type (2016-2027) Figure 33. Europe Infectious Disease Drugs Market Share by Application (2016-2027) Figure 34. Europe Infectious Disease Drugs Market Share by Country (2016-2027) Figure 35. Germany Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. France Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. U.K. Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Italy Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Russia Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Nordic Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Asia-Pacific Infectious Disease Drugs Market Share by Type (2016-2027) Figure 43. Asia-Pacific Infectious Disease Drugs Market Share by Application (2016-2027) Figure 44. Asia-Pacific Infectious Disease Drugs Market Share by Region (2016-2027) Figure 45. China Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Japan Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. South Korea Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Southeast Asia Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. India Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Australia Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Latin America Infectious Disease Drugs Market Share by Type (2016-2027) Figure 53. Latin America Infectious Disease Drugs Market Share by Application (2016-2027) Figure 54. Latin America Infectious Disease Drugs Market Share by Country (2016-2027) Figure 55. Mexico Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Brazil Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Middle East & Africa Infectious Disease Drugs Market Share by Type (2016-2027) Figure 59. Middle East & Africa Infectious Disease Drugs Market Share by Application (2016-2027) Figure 60. Middle East & Africa Infectious Disease Drugs Market Share by Country (2016-2027) Figure 61. Turkey Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Saudi Arabia Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. UAE Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. GlaxoSmithKline Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021) Figure 65. Gilead Sciences Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021) Figure 66. Merck & Co. Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021) Figure 67. Pfizer Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021) Figure 68. Sanofi Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021) Figure 69. AbbVie Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021) Figure 70. Shire Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021) Figure 71. Grifols Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021) Figure 72. Johnson & Johnson Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021) Figure 73. Protein Sciences Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021) Figure 74. AstraZeneca Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021) Figure 75. Bottom-up and Top-down Approaches for This Report Figure 76. Data Triangulation Figure 77. Key Executives Interviewed

GlaxoSmithKline Gilead Sciences Merck & Co. Pfizer Sanofi AbbVie Shire Grifols Johnson & Johnson Protein Sciences AstraZeneca